Analysed Intellia Therapeutics Inc (NTLA:NASDAQ) News Sources
Intellia Therapeutics Announces FDA Lift of Clinical Hold on MAGNITUDE Phase 3 Clinical Trial in ATTR-CM
Yahoo Finance
Intellia Therapeutics Presents Longer-Term Clinical Data for Lonvoguran Ziclumeran (lonvo-z); Hereditary Angioedema (HAE) Patient-Focused Research at AAAAI 2026
Yahoo Finance
US FDA lifts clinical hold of Intellia Therapeutics’ MAGNITUDE phase 3 trial of nex-z for patients with transthyretin amyloidosis with cardiomyopathy
Pharmabiz
Intellia Therapeutics Announces Fourth Quarter and Full-Year 2025 Financial Results and Business Updates
Yahoo Finance UK
What is the current price of Intellia Therapeutics Inc (NTLA:NASDAQ)?
The current price of Intellia Therapeutics Inc (NTLA:NASDAQ) is $13.44.
Intellia Therapeutics Inc (NTLA:NASDAQ) absolute price change since previous trading day?
The absolute price change of Intellia Therapeutics Inc (NTLA:NASDAQ) since the previous trading day is $0.29.
Intellia Therapeutics Inc (NTLA:NASDAQ) percentage price change since previous trading day?
The percentage price change of Intellia Therapeutics Inc (NTLA:NASDAQ) since the previous trading day is 2.21%.
What is This Week's average sentiment score for Intellia Therapeutics Inc (NTLA:NASDAQ)?
This Week's average sentiment score for Intellia Therapeutics Inc (NTLA:NASDAQ) is 90 out of 100.
What is This Week's average sentiment for Intellia Therapeutics Inc (NTLA:NASDAQ)?
This Week's sentiment for Intellia Therapeutics Inc (NTLA:NASDAQ) is .
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.